Beta Bionics CPO Sells Shares in Rule‑10b5‑1 Plan Amid Bull‑Run – Is It a Warning or Routine Cash‑Flow Move?
Beta Bionics insider sale: CPO Mike Mensinger sells 2,200 shares at $30.10 in a planned move—what this means for investors, growth prospects, and market volatility.
3 minutes to read